Fenoldopam

CHEMBL588 Phase 4 Approuvé Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
305.8 g/mol
LogP
2.4
Phase
4

This medication works by activating dopamine receptors in the kidneys and blood vessels, causing them to widen and lower blood pressure while improving kidney blood flow. It is typically given intravenously in hospital settings for rapid blood pressure control.

Masse moléculaire

305,7500 g/mol

LogP

2,40

TPSA

72,70 Ų

Règle des 5 de Lipinski

Conforme

Aires thérapeutiques

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Structure 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

Oc1ccc(C2CNCCc3c2cc(O)c(O)c3Cl)cc1

InChI

InChI=1S/C16H16ClNO3/c17-15-11-5-6-18-8-13(9-1-3-10(19)4-2-9)12(11)7-14(20)16(15)21/h1-4,7,13,18-21H,5-6,8H2

Molecular Formula

C16H16ClNO3

HBD / HBA

4 / 4

Liaisons Rotatives

1

Atomes Lourds

21

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

This medication works by activating dopamine receptors in the kidneys and blood vessels, causing them to widen and lower blood pressure while improving kidney blood flow. It is typically given intravenously in hospital settings for rapid blood pressure control.

Yes, Fenoldopam is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL588. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 3341. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.